These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F; J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247 [TBL] [Abstract][Full Text] [Related]
3. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US. Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038 [TBL] [Abstract][Full Text] [Related]
4. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification. Smereka P; Doshi AM; Lavelle LP; Shanbhogue K AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909 [No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276 [TBL] [Abstract][Full Text] [Related]
6. Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution. Tang ES; Hall G; Yu D; Menard A; Hopman W; Nanji S Ann Surg Oncol; 2019 Aug; 26(8):2560-2567. PubMed ID: 31025229 [TBL] [Abstract][Full Text] [Related]
7. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know. Tang A; Valasek MA; Sirlin CB Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514 [TBL] [Abstract][Full Text] [Related]
8. Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm. Zhong X; Guan T; Tang D; Li J; Lu B; Cui S; Tang H BMC Gastroenterol; 2021 Apr; 21(1):155. PubMed ID: 33827440 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound. Abd Alkhalik Basha M; Abd El Aziz El Sammak D; El Sammak AA Clin Radiol; 2017 Oct; 72(10):901.e1-901.e11. PubMed ID: 28673446 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review. van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016 [TBL] [Abstract][Full Text] [Related]
13. Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale. Esposito A; Buscarino V; Raciti D; Casiraghi E; Manini M; Biondetti P; Forzenigo L Radiol Med; 2020 Jan; 125(1):15-23. PubMed ID: 31587182 [TBL] [Abstract][Full Text] [Related]
14. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations. Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793 [No Abstract] [Full Text] [Related]
15. Cirrhotic liver: What's that nodule? The LI-RADS approach. Shah A; Tang A; Santillan C; Sirlin C J Magn Reson Imaging; 2016 Feb; 43(2):281-94. PubMed ID: 25996905 [TBL] [Abstract][Full Text] [Related]
19. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis. Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943 [TBL] [Abstract][Full Text] [Related]
20. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm. An C; Rakhmonova G; Choi JY; Kim MJ Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]